Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
30 participants
OBSERVATIONAL
2021-02-01
2028-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Natural History Study for Achromatopsia
NCT04124185
Retrospective Natural History Study of Retinitis Pigmentosa
NCT03975543
Prospective Natural History Study of Retinitis Pigmentosa
NCT04285398
In Depth Observational Clinical Trial Of Retinitis Pigmentosa Patients
NCT05849987
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa
NCT06368375
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical examinations
Clinical examinations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Or disease-causing mutation involving the PRPF31 gene without the clinical diagnosis of retinitis pigmentosa
Exclusion Criteria
* Other types of retinitis pigmentosa
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oslo University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Josephine Prener Holtan
Senior Consultant, MD PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Josephine P Holtan, MD, PHD
Role: PRINCIPAL_INVESTIGATOR
Department of Ophthalmology, Oslo University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Ophthalmology, Oslo University Hospital
Oslo, , Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
179417
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.